A new zinc chelator, IPZ-010 ameliorates postoperative ileus

Biomed Pharmacother. 2020 Mar:123:109773. doi: 10.1016/j.biopha.2019.109773. Epub 2019 Dec 18.

Abstract

Zinc was discovered to be a novel second messenger in immunoreactive cells. We synthesized a novel free zinc chelator, IPZ-010. Here, we investigated the effects of IPZ-010 in a mouse postoperative ileus model and determined the effects of zinc signal inhibition as a new therapeutic strategy against postoperative ileus. Zinc waves were measured in bone marrow-derived mast cells (BMMCs) loaded with a zinc indicator, Newport green. Degranulation and cytokine expression were measured in BMMCs and bone marrow-derived macrophages (BMDMs). Postoperative ileus model mice were established with intestinal manipulation. Mice were treated with IPZ-010 (30 mg/kg, s.c. or p.o.) 1 h before and 2 h and 4 h after intestinal manipulation. Gastrointestinal transit, inflammatory cell infiltration, and expression of inflammatory mediators were measured. Free zinc waves occurred following antigen stimulation in BMMCs and were blocked by IPZ-010. IPZ-010 inhibited interleukin-6 secretion and degranulation in BMMCs. IPZ-010 inhibited tumor necrosis factor-α mRNA expression in BMMCs stimulated with lipopolysaccharide or adenosine triphosphate, whereas IPZ-010 had no effects on tumor necrosis factor-α mRNA expression in BMDMs stimulated with lipopolysaccharide or adenosine triphosphate. In postoperative ileus model mice, IPZ-010 inhibited leukocyte infiltration and cytokine expression, which ameliorated gastrointestinal transit. Furthermore, ketotifen (1 mg/kg) induced similar effects as IPZ-010. These effects were not amplified by co-administration of IPZ-010 and ketotifen. IPZ-010 inhibited zinc waves, resulting in inhibition of inflammatory responses in activated BMMCs in vitro. Targeting zinc waves in inflammatory cells may be a novel therapeutic strategy for treating postoperative ileus.

Keywords: Inflammation; Macrophages; Mast cells; Postoperative ileus; Zinc.

MeSH terms

  • Adenosine Triphosphate / pharmacology
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Antigens, CD / metabolism
  • Antigens, Differentiation, Myelomonocytic / metabolism
  • Chelating Agents / chemistry
  • Chelating Agents / pharmacology
  • Chelating Agents / therapeutic use*
  • Disease Models, Animal
  • Ethylenediamines / pharmacology
  • Ethylenediamines / therapeutic use
  • Gastrointestinal Transit / drug effects
  • Ileus / drug therapy*
  • Ileus / pathology
  • Ileus / physiopathology
  • Inflammation Mediators / metabolism
  • Ketotifen / pharmacology
  • Lipopolysaccharides / pharmacology
  • Macrophages / metabolism
  • Mast Cells / drug effects
  • Mast Cells / metabolism
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Neutrophils / metabolism
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / pathology
  • Postoperative Complications / physiopathology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Zinc / metabolism*

Substances

  • Anti-Inflammatory Agents
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD68 antigen, human
  • Chelating Agents
  • Ethylenediamines
  • Inflammation Mediators
  • Lipopolysaccharides
  • RNA, Messenger
  • Adenosine Triphosphate
  • Zinc
  • N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine
  • Ketotifen